General description
INN
Certolizumab pegol
Medicine type
Biological agent
EML status history
First added in 2023
(TRS
1049)
for
Rheumatoid arthritis
Changed in 2023
(TRS
1049)
for
Axial spondyloarthritis
Changed in 2023
(TRS
1049)
for
Juvenile idiopathic arthritis
Changed in 2023
(TRS
1049)
for
Crohn disease site
Therapeutic equivalent for
Wikipedia
DrugBank